Jeffrey Kraws

Jeffrey J.
Kraws is the founder of Cra Advisors LLC, founded in 2003, serving as Chief Executive Officer.
Mr. Kraws is the founder of TopHat Capital LLC, founded in 2012, serving as Partner.
Mr. Kraws was the founder of Crystal Research Associates, founded in 2003, serving as Chief Executive Officer.
Current jobs include Independent Non-Executive Chairman at Theriva Biologics, Inc. since 2012, Director at Voyageur Pharmaceuticals Ltd., Head-Corporate Strategy & Development at Kazia Therapeutics Ltd., Partner at Phoenix Holdings Ltd. (US) since 2015, Partner at Grannus Securities Pty Ltd. since 2015, and Partner at US Medical Innovations LLC.
Former jobs include Independent Chairman at Avivagen, Inc. from 2019 to 2023, Managing Director-Healthcare Research at Ryan, Beck & Co., Inc., Director at Saleen Automotive, Inc. from 2013 to 2020, Managing Director & Research Director at Gruntal & Co. LLC, Director at Innovation1 Biotech, Inc. from 2022 to 2023, Senior Analyst at The Buckingham Research Group, Inc., MD-Healthcare Research Group at First Union Securities, President at IRG Research Group, Chief Financial Officer at Syncromune, Inc., Co-President at The Investor Relations Group, Inc., President at Ra Medical Systems, Inc. from 2019 to 2021, and President-Brokerage & Investment Banking Operation at Abb Aros Securities, Inc. Education includes an MBA from Cornell University conferred in 1988 and an undergraduate degree from State University of New York at Buffalo conferred in 1986.